Salarius Pharmaceuticals to Deliver Virtual Presentation at the Emerging Growth Invitational
HOUSTON, April 22, 2020 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage oncology company targeting cancers caused by dysregulated […]